Syz Group boosts net profit by 16% in 2023 full-year results
Assets under management sit at CHF 23.1bn
Coronavirus weekly round-up: NHS England hands out first Moderna jabs as J&J EU rollout stumbles and doubts cast on Tokyo Olympics
Six investors mull the events shaping portfolios over the past week
